Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Study of an Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stone Disease

NCT: NCT04771182 · TERMINATED

NCT IDNCT04771182
StatusTERMINATED
Start Date2019-02-08
Completion2022-10-05

Brief Summary

This is a single arm, multi-center study to assess the safety and efficacy of a form of extracorporeally induced lithotripsy, called the Enhanced Lithotripsy System, to treat urinary stones.

Frequently Asked Questions

What is Study of an Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stone Disease?

Study of an Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stone Disease is a clinical trial registered under NCT04771182. Current status: TERMINATED.

What is the status of NCT04771182?

The current status of NCT04771182 (Study of an Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stone Disease) is: TERMINATED.

When did Study of an Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stone Disease start?

Study of an Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stone Disease started on 2019-02-08.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑